Document Detail


Extended daily dialysis in acute renal failure: a new therapeutic approach.
MedLine Citation:
PMID:  19363279     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Although intermittent hemodialysis (IHD) is the standard therapy in patients with acute renal failure, it is associated with several drawbacks. Extended daily dialysis (EDD) has been described as a compromise between IHD and continuous therapies and could potentially overcome problems associated with IHD. MATERIALS AND METHODS: We compared EDD with IHD each administered in 15 patients with acute renal failure. The IHD was administered 4 hours per session thrice weekly, while EDD was given for 8 hours per session daily with the same machines at similar blood and dialysate flow rates. Treatment outcome, metabolic control, and hemodynamic stability were assessed in the patients of each group. RESULTS: A total of 140 EDD treatment sessions and 82 IHD sessions were administered. Patients in the EDD and the IHD groups received a mean of 74.67 +/- 29.70 hours and 21.73 +/- 5.99 hours of dialysis, respectively (P < .001). The median urea reduction ratio in the EDD group was significantly higher (83.82% versus 64.66%, P < .001). Patients on EDD showed faster normalization of deranged metabolic parameters. Hemodynamically, EDD was better tolerated compared to IHD. The median predialysis mean arterial pressure in the EDD and IHD patients were 103.3 mm Hg and 100 mm Hg, respectively, while the postdialysis values were 78.6 mm Hg and 73 mm Hg, respectively. CONCLUSIONS: Extended daily dialysis appears to be a promising technique for dialysis in moderately ill patients having up to 2 organ failures.
Authors:
Nirmal Kumar; Ravinder S Ahlawat
Related Documents :
10023649 - Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patien...
2080789 - Systemic involvement of dialysis-amyloidosis.
8725679 - Anemia severity and missed dialysis treatments in erythropoietin-treated hemodialysis p...
20880929 - Progression of aortic calcification is associated with disorders of mineral metabolism ...
15083919 - Effects of different dialysis modalities on cardiac autonomic dysfunctions in end-stage...
18972259 - The aminothiol redox status in haemodialysis patients does not improve with folate ther...
6984219 - Esophageal function after sclerotherapy of bleeding varices.
24764259 - Interferon-α is not elevated in idiopathic thrombotic thrombocytopenic purpura patients.
8272289 - One hundred unstable bladders.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Iranian journal of kidney diseases     Volume:  1     ISSN:  1735-8582     ISO Abbreviation:  Iran J Kidney Dis     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2009-04-13     Completed Date:  2009-05-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101316967     Medline TA:  Iran J Kidney Dis     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  63-72     Citation Subset:  IM    
Affiliation:
Department of Medicine, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India. doc.nirmal@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Pressure
Female
Hemodiafiltration
Humans
Hydrogen-Ion Concentration
Kidney Failure, Acute / blood,  physiopathology,  therapy*
Male
Middle Aged
Potassium / blood
Renal Dialysis / methods*
Survival Analysis
Treatment Outcome
Urea / blood
Young Adult
Chemical
Reg. No./Substance:
57-13-6/Urea; 7440-09-7/Potassium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nephrology research output in iran in a decade.
Next Document:  Montelukast for treatment of refractory pruritus in patients on hemodialysis.